50 Million Doses Of Covaxin Set To Expire Early 2023: Report

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.

from NDTV News-Latest https://ift.tt/OVYWbpP